Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rudolph Schrot

Neurological Surgery Sacramento, CA Medical Doctor

NPI 1790768679 CMS profile 80721

2800 L St, Suite 500, Sacramento, CA 95816

Open in the dashboard

General payments

$48,010

193 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$121,577 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Rudolph Schrot of Sacramento, CA is reported in the CMS Open Payments database as having received $48,010 across 193 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $121,577 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,357 18
2024 General $1,167 10
2023 General $5,238 21
2022 General $5,558 30
2021 General $1,771 16
2020 General $5,693 34
2019 General $27,226 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rudolph Schrot
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Rudolph Schrot were reported at $1,357. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Rudolph Schrot Neurological Surgery median Middle half National median
2019 $27,226 $582 $138–$3,006 $163
2020 $5,693 $294 $76–$2,174 $114
2021 $1,771 $387 $105–$2,432 $132
2022 $5,558 $542 $139–$2,989 $149
2023 $5,238 $534 $145–$2,697 $160
2024 $1,167 $574 $155–$3,046 $164
2025 $1,357 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $29,455 33 payments
  2. Medtronic, Inc. $7,434 17 payments
  3. Nevro Corp. $2,772 28 payments
  4. Centinel Spine, LLC $1,697 15 payments
  5. Abbott Laboratories $1,484 42 payments
  6. Boston Scientific Corporation $818 11 payments
  7. Zimmer Biomet Holdings, Inc. $807 4 payments
  8. Alphatec Spine, Inc $428 2 payments
  9. Globus Medical, Inc. $411 8 payments
  10. RTI Surgical, Inc. $392 3 payments
  11. Other $2,312 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $27,000 10 payments
  2. Food and Beverage $8,284 143 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,380 2 payments
  4. Travel and Lodging $6,346 38 payments
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $27,970 28 payments
  2. INTELLIS ADAPTIVESTIM $3,912 12 payments
  3. RESTORESENSORSURESCAN $3,190 1 payment
  4. Senza Spinal Cord Stimulation System $2,662 26 payments
  5. PRODISC C VIVO $1,198 8 payments
  6. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $864 3 payments
  7. ROSA-Brain $709 3 payments
  8. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $541 1 payment
  9. PROCLAIM $431 11 payments
  10. Other - Miscellaneous $428 2 payments
  11. Other $8,046 117 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

31

Median for Neurosurgery: 83

Drug cost

$154

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 31 $154

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 100 billing codes

Paid by Medicare

$190,366

Medicare's payments for the services billed

Medicare patients

328

Average age 70

Services billed

777

205 women, 123 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Depression 31%
Diabetes 28%
Ischemic heart disease 22%
Chronic kidney disease 20%
Osteoporosis 20%
Heart failure 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

193 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record